GeoVax Labs And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed lower by around 69 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Aspen Group

• The Trade: Aspen Group, Inc. (OTC:ASPU) Director Douglas Kass acquired a total of 47,500 shares an average price of $0.18. To acquire these shares, it cost around $8,446.
• What’s Happening: Aspen Group recently announced closing of $12.4 million private placement.
• What Aspen Group Does: Aspen Group Inc is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again.

Fortress Biotech

• The Trade: Fortress Biotech, Inc. (NASDAQ:FBIO) President, CEO and Chairman MD Lindsay Rosenwald acquired a total of 100,000 shares at an average price of $0.28. To acquire these shares, it cost around $28,330.
• What’s Happening: Fortress Biotech posted a narrower loss for the second quarter.
• What Fortress Biotech Does: Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products.

Check This Out: Top 2 Materials Stocks That May Implode This Quarter

Red Cat Holdings

• The Trade: Red Cat Holdings, Inc. (NASDAQ:RCAT) COO Allan Thomas Evans acquired a total of 10,000 shares at an average price of $0.97. The insider spent $18,800 to buy those shares.
• What’s Happening: Red Cat Holdings posted in-line loss for the first quarter.
• What Red Cat Holdings Does: Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders.

GeoVax Labs

• The Trade: GeoVax Labs, Inc. (NASDAQ:GOVX) Chief Medical Officer Kelly McKee acquired a total of 9,653 shares at an average price of $0.52. The insider spent around $5,020.
• What’s Happening: GeoVax Labs and ProBioGen announced the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1.CR.pIX® suspension cell line.
• What GeoVax Labs Does: Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms.

Don’t forget to check out our premarket coverage here